MedTrace Logo

Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study

NCT04579471 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-07-03

No results posted yet for this study

Summary

This project will provide novel data using a large cohort of more than 3000 transplanted patients. Risk and protective factors for SARS-CoV-2 infection and COVID-19 disease severity will be identified. The proportion of patients who develop antibodies after infection will be revealed. In this way the presence of these antibodies can be evaluated as a test for prior infection. Our study additionally will demonstrate how long these antibodies remain present and whether they are protective against a new infection.

Conditions

  • Covid19
  • SARS-CoV Infection
  • Transplantation Infection

Interventions

DIAGNOSTIC_TEST

SARS-CoV-2 IgG

Collection of clinical variables, assessment of IgG antibodies for SARS-CoV-2, plasma collection for translational immunology studies

Sponsors & Collaborators

  • KU Leuven

    collaborator OTHER

  • Hasselt University

    collaborator OTHER

  • Ziekenhuis Oost-Limburg

    collaborator OTHER

  • Jessa Hospital

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Principal Investigators

  • Jef Verbeek, MD, PhD · UZ Leuven

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2021-12-31
Completion
2025-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04579471 on ClinicalTrials.gov